| scholarly article | Q13442814 |
| P2093 | author name string | Harald Seifert | |
| Dietrich Mack | |||
| Irith Wiegand | |||
| Enno Stürenburg | |||
| Heinrich K Geiss | |||
| P2860 | cites work | Extended-spectrum beta-lactamases: a clinical update | Q24534999 |
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | Q34201311 | ||
| Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method | Q34974437 | ||
| Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control | Q35558473 | ||
| Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community | Q36139832 | ||
| Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. | Q36279116 | ||
| The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter | Q36550851 | ||
| Properties of plasmids responsible for production of extended-spectrum beta-lactamases | Q36752663 | ||
| A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg | Q39143121 | ||
| Evolution of plasmid-coded resistance to broad-spectrum cephalosporins | Q39850194 | ||
| Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. | Q40014335 | ||
| Biochemical and genetic characterization of the beta-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and "Y. ruckeri" strains | Q41458385 | ||
| Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests | Q41878926 | ||
| Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. | Q42130010 | ||
| Detection of beta-lactamase-mediated resistance | Q43649165 | ||
| Effect of D240G substitution in a novel ESBL CTX-M-27. | Q44459209 | ||
| Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan | Q44481918 | ||
| Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases | Q44583930 | ||
| False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase | Q44764324 | ||
| Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection | Q44901126 | ||
| Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria | Q45096410 | ||
| Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. | Q52864073 | ||
| Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. | Q53941913 | ||
| Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | Q54380570 | ||
| Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. | Q54589161 | ||
| Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. | Q54631687 | ||
| Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. | Q54745885 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Enterobacteriaceae | Q380136 |
| P304 | page(s) | 1167-1174 | |
| P577 | publication date | 2007-02-07 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | |
| P478 | volume | 45 |
| Q92635807 | A High Resolution DNA Melting Curve Analysis for the Rapid and Efficient Molecular Diagnostics of Extended Spectrum β-Lactamase Determinants from Foodborne Escherichia coli |
| Q34750112 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances |
| Q53552462 | Amperometric detection of extended-spectrum β-lactamase activity: application to the characterization of resistant E. coli strains. |
| Q64228462 | Analysis of bacterial contamination and antibiotic residue of beef meat from city slaughterhouses in East Java Province, Indonesia |
| Q34456773 | Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment |
| Q37158193 | Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang |
| Q37621552 | Antimicrobial susceptibility testing: a primer for clinicians |
| Q41963223 | Broth microdilution method to detect extended-spectrum beta-lactamases and AmpC beta-lactamases in enterobacteriaceae isolates by use of clavulanic acid and boronic acid as inhibitors |
| Q96304174 | Characterization of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients |
| Q45109252 | Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles |
| Q41939169 | Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases |
| Q85389988 | Comparison of different phenotypic assays for the detection of extended-spectrum β-lactamase production by inducible AmpC-producing Gram-negative bacilli |
| Q34741114 | Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. |
| Q42282929 | Continuous surveillance to reduce extended-spectrum β-lactamase Klebsiella pneumoniae colonization in the neonatal intensive care unit |
| Q41971522 | Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago |
| Q39762100 | Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms |
| Q83242570 | Dominance of CTX-M group 1 beta-lactamase enzymes in ESBL producing E. coli from outpatient urines in neighboring regions of Austria and Italy |
| Q35101453 | ESBLs: A Clear and Present Danger? |
| Q26749590 | Escherichia coli β-Lactamases: What Really Matters |
| Q54369631 | Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods. |
| Q83341760 | Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes |
| Q35090146 | Expert systems in clinical microbiology |
| Q43248345 | Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium |
| Q37091253 | Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern |
| Q43155418 | Extended-spectrum beta-lactamases in enterobacteria other than Escherichia coli and Klebsiella |
| Q80625597 | Fatal endocarditis due to extended spectrum betalactamase producing Klebsiella terrigena in a liver transplant recipient |
| Q40282132 | Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study |
| Q43977571 | Gastrointestinal colonization with ESBL-producing Klebsiella in preterm babies--is vancomycin to blame? |
| Q43314778 | High dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae in effluents from wastewater treatment plants. |
| Q43589685 | In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany |
| Q39919691 | Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes |
| Q54334036 | Involvement of virulence properties and antibiotic resistance in Escherichia coli strains causing pyelonephritis in children. |
| Q36150730 | Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy |
| Q40029789 | Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany, October to November 2015. |
| Q37291349 | Multiresistant Enterobacteriaceae: new threat of an old problem |
| Q35533202 | Pathogenic and commensal Escherichia coli from irrigation water show potential in transmission of extended spectrum and AmpC β-lactamases determinants to isolates from lettuce |
| Q33920474 | Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers |
| Q45850774 | Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections |
| Q42565997 | Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. |
| Q34532991 | Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands |
| Q35738292 | Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology |
| Q46298651 | Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing |
| Q39916554 | Resistance patterns, ESBL genes, and genetic relatedness of Escherichia coli from dogs and owners. |
| Q37290720 | Resistant gram-negative infections in the outpatient setting in Latin America |
| Q89565775 | Shigella flexneri: an emerging pathogen |
| Q31140745 | Standardisation of disk diffusion results for antibiotic susceptibility testing using the sirscan automated zone reader |
| Q37892237 | The challenges of antimicrobial drug resistance in Greece |
| Q36449603 | The continuing challenge of ESBLs |
| Q38766625 | The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC. |
| Q47647157 | Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia |
| Q54394159 | [Prevalence of the TEM, SHV and CTX-M families of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp at the University Hospital of Santa Maria, State of Rio Grande do Sul]. |
Search more.